The FDA has ordered a label change for a number of osteoporosis drugs after concerns their long-term use raises the …
Warner Chilcott has assumed all commercial responsibility for its osteoporosis drug Actonel in the US. Sanofi-Aventis has agreed to pass …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

